CompaniesByCap
ZTS
Zoetis Inc. (ZTS)
NYSE · Healthcare

Zoetis Inc. Revenue 2011–2025

Zoetis Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Zoetis Inc. revenue for the quarter ending March 31, 2026 was 2.3 B, a 2.91% increase year-over-year.
  • Zoetis Inc. revenue for the twelve months ending March 31, 2026 was 9.3 B, a 2.53% increase year-over-year.
  • Zoetis Inc. annual revenue for 2025 was 9.5 B, a 2.28% increase from 2024.
  • Zoetis Inc. annual revenue for 2024 was 9.3 B, a 8.33% increase from 2023.
  • Zoetis Inc. annual revenue for 2023 was 8.5 B, a 5.74% increase from 2022.
  • Zoetis Inc. annual revenue for 2022 was 8.1 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Zoetis Inc. (ZTS) — Frequently Asked Questions

Zoetis Inc. (ZTS) is a publicly traded US company. It has a market capitalization of $36.08B. In fiscal 2025 it reported revenue of $9.47B and net income of $2.67B. Explore ZTS's stock price, financial statements, earnings history, margins and key ratios below.

What is Zoetis Inc.'s market cap?

Zoetis Inc. (ZTS) has a market capitalization of $36.08B.

What is the ZTS stock price?

ZTS trades at $81.29 (-1.11% on the day).

How much revenue does Zoetis Inc. make?

Zoetis Inc. reported revenue of $9.47B in fiscal 2025.

Is ZTS profitable?

In fiscal 2025, Zoetis Inc. reported net income of $2.67B.